Trinity Biotech (TRIB) Dividends Paid - Common Growth (1y) (2010 - 2024)
Trinity Biotech (TRIB) Dividends Paid - Common Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 7.09% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 4.98% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.23% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 0.00% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -11.74% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 9.25% |
| 10 | Trinity Biotech | 6.46 Mn | 1.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 39.99% |
| Dec 31, 2023 | -43.89% |
| Sep 30, 2023 | -13.69% |
| Dec 31, 2022 | -74.61% |
| Sep 30, 2022 | -73.60% |
| Mar 31, 2022 | -68.98% |
| Dec 31, 2021 | -5.19% |
| Sep 30, 2021 | 38.00% |
| Jun 30, 2021 | 83.80% |
| Mar 31, 2021 | 143.71% |
| Dec 31, 2020 | 66.63% |
| Sep 30, 2020 | -20.65% |
| Jun 30, 2020 | -37.70% |
| Mar 31, 2020 | -55.00% |
| Dec 31, 2019 | -45.83% |
| Sep 30, 2019 | -29.68% |
| Jun 30, 2019 | -49.44% |
| Mar 31, 2019 | -45.39% |
| Dec 31, 2018 | -47.44% |
| Sep 30, 2018 | -42.94% |